Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Tiotropium for asthma

A summary of current guidelines and a case study

Shedd, Glenn Clinton DNP, FNP-BC; Blenis, Robert Colin BSN, RN

Journal of the American Association of Nurse Practitioners: August 2018 - Volume 30 - Issue 8 - p 460–463
doi: 10.1097/JXX.0000000000000053
Clinical and Case Study Article
Buy

Background and purpose: The long-acting muscarinic antagonist tiotropium received an indication for the treatment of asthma from the FDA in 2015.

Methods: This paper summarizes much of the published findings on tiotropium and asthma and explores the heterogeneity of the asthma population vis-à-vis recent changes in guidelines for management of COPD. The accompanying case study provides an illustration of how tiotropium might be added to a patient's regimen appropriately.

Conclusions and implications for practice: Tiotropium has been shown in many studies to be beneficial to patients with asthma as an add-on medication. It should be considered as an agent by the clinician managing patients with both allergic and non-allergic asthma.

Emory University Nell Hodgson Woodruff School of Nursing, Atlanta, Georgia

Correspondence: Glenn Clinton Shedd, DNP, FNP-BC, Emory University Nell Hodgson Woodruff School of Nursing, Atlanta, Georgia. E-mail: gshedd@emory.edu

Competing interests: The authors report no conflicts of interest.

Received January 11, 2018

Received in revised form March 06, 2018

Accepted March 07, 2018

© 2018 American Association of Nurse Practitioners
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website